Expert discussions are underway on the lifting of bans on cannabis-derived drugs in Japan. The government is set to create the environment needed to allow for the utilization of such medicines by embracing this policy in its annual “honebuto” paper,…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION RAD-AR Council to Set Guidelines for Information Provisioning on Ethical Drugs
February 12, 2013
-
ORGANIZATION JMA Exec. Mikami Wants a Hold on Info Disclosures Based on Transparency Guidelines
February 8, 2013
-
BUSINESS Pfizer Confident about Joining Top 3 in Japan Generic Sales by around 2015: Unit Chief Matsumori
February 7, 2013
-
REGULATORY NIHS to Accelerate Medical Innovation Research
February 7, 2013
-
BUSINESS Novartis Jettisons Key Evidence from Diovan Promotion
February 6, 2013
-
BUSINESS Nesp, Mircera Jostling for Market Shares of Pre-Dialysis CKD Patients
February 5, 2013
-
BUSINESS Aricept Fails to Meet Minimum Sales Target in Japan: Eisai
February 4, 2013
-
BUSINESS Marketing Ability Could Become Decisive Factor as All DPP-4 Inhibitors Are Likely to Obtain the Same Concurrent-use Indications
February 4, 2013
-
BUSINESS Daiichi Sankyo Sees 7.1% Sales Rise in April-December, Cuts Domestic Forecast for Nexium
February 1, 2013
-
REGULATORY CRO Association to Compile Guidelines for Third-Party Outsourcing after GCP Revision
February 1, 2013
-
ORGANIZATION Wholesale Industry FTC Prohibits Drink Donations at Academic Confabs, Keeps Pace with Drug Makers
January 31, 2013
-
REGULATORY 13 Generic Makers Slapped with Improvement Order due to South Korean Supplier’s GMP Violation
January 30, 2013
-
ORGANIZATION Wholesale Industry FTC Curbs Returns of Drugs to Be Discarded
January 29, 2013
-
BUSINESS Medipal Group Introduces Special Mini Cooler for New Orphan Drug
January 29, 2013
-
REGULATORY PAFSC First Committee on New Drugs to Discuss Approval of Japan’s First FD Treatment
January 28, 2013
-
BUSINESS Novartis, Sanofi Dissolve Partnership on Equa Copromotion
January 25, 2013
-
BUSINESS Transparency GL: Drug Makers Might Disclose Individual Payments Only Upon Request
January 24, 2013
-
BUSINESS Merck Serono Aims for Top 10 Slot in Oncology Field
January 23, 2013
-
BUSINESS Sanofi’s Dellegra Promotion to Home in on Stuffy Nose
January 22, 2013
-
BUSINESS Pfizer Detailing Infectious Disease Portfolios across Divisions
January 21, 2013
ページ
“The Tesla and SpaceX CEO sent an email to employees at both companies on Tuesday saying everyone must spend 40 hours per week in the office. ‘If you don’t show up, we will assume you have resigned. The more senior…
The average ratio of females in managerial posts at Japanese drug makers has finally reached a double-digit number, at 10.0%, a Jiho survey found. However, this is still well below a near-25% ratio logged by foreign players operating in the…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…
A total of 15 new drugs (APIs) joined the NHI price list in 2021 with peak sales forecasts topping at 10 billion yen, many of them in the area of orphan diseases and with few mega launches, according to a…